![Peter Groenewegen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Peter Groenewegen
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Chiesi Pharmaceuticals BV
![]() Chiesi Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Chiesi Pharmaceuticals BV provides research, development and sale of medical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company is headquartered in Rijswijk, the Netherlands.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peter Groenewegen tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
CHIESI Farmaceutici SpA
![]() CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Pharmaceuticals: Major | General Counsel | |
Opocrin SRL | Director/Board Member | ||
Chiesi SA (Belgium)
![]() Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Pharmaceuticals: Major | Director/Board Member | |
Chiesi Pharmaceuticals Shanghai Co. Ltd. | Director/Board Member | ||
Chiesi España SA
![]() Chiesi España SA Pharmaceuticals: MajorHealth Technology Chiesi España SA manufactures and distributes pharmaceutical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation, and neonatology. The firm produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It also provides solutions for the treatment of asthma and chronic obstructive pulmonary diseases. The company is headquartered in Barcelona, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Chiesi Pharmaceuticals, Inc. | Director/Board Member | ||
Chiesi Pharmaceuticals (Pvt) Ltd. | Director/Board Member | ||
Novadynamics Healthcare SRL | Director/Board Member | ||
Opocrin SpA
![]() Opocrin SpA Pharmaceuticals: MajorHealth Technology Opocrin SpA engages in the manufacture and marketing of active ingredients for the pharmaceutical industry. Its products include Collagen Gel, Sodium and Calcium Heparin, Iron Complexes, Parnaparin, and Pulmonary Surfactant. The company was founded by Pietro Bianchini in 1964 and is headquartered in Modena, Italy. | Pharmaceuticals: Major | Director/Board Member | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Chiesi International Holding BV | Director/Board Member | ||
Chiesi Hellas Pharmaceuticals SA
![]() Chiesi Hellas Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Chiesi Hellas Pharmaceuticals SA provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary disease. The company is headquartered in Vrilissa, Greece. | Pharmaceuticals: Major | Director/Board Member | |
Chiesi SAS
![]() Chiesi SAS Pharmaceuticals: GenericHealth Technology Chiesi SAS wholesales and distributes pharmaceutical products. The company was founded in 1992 and is headquartered in Bois-Colombes, France. | Pharmaceuticals: Generic | Director/Board Member | |
Chiesi Healthcare Ltd. | Director/Board Member | ||
Chiesi Ltd.
![]() Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Cheshire Healthcare Ltd. | Director/Board Member | ||
University of Parma | College/University | Graduate Degree | |
Amryt Pharma Holdings Ltd.
![]() Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Italia | 6 |
Regno Unito | 5 |
Stati Uniti | 3 |
Belgio | 2 |
Cina | 2 |
Settori
Health Technology | 9 |
Electronic Technology | 2 |
Consumer Services | 2 |
Posizioni
Director/Board Member | 17 |
Chief Executive Officer | 1 |
General Counsel | 1 |
Independent Dir/Board Member | 1 |
Graduate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
Marco Vecchia | 19 |
- Borsa valori
- Insiders
- Peter Groenewegen
- Connessioni Società